Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer-论文-万方医学网

首页> > Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer

Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer

导出原文传递

翻译打印收藏纠错

第一作者： Satake, Hironaga

作者： Satake, Hironaga ^[1] ; Kagawa, Yoshinori ^[2] ; Shinozaki, Eiji ^[3] ; Tanizawa, Yoshinori ^[4] ; Jin, Long ^[5] ; Cai, Zhihong ; Makiyama, Akitaka

作者单位： Dept Med Oncol,Kochi Med Sch ^[1] Dept Gastroenterol Surg,Osaka Gen Med Ctr ^[2] Canc Inst Hosp,Japanese Fdn Canc Res ^[3] Japan Drug Dev & Med Affairs,Eli Lilly Japan KK ^[4] Canc Ctr,Gifu Univ Hosp ^[5]

关键词 Aflibercept Angiogenesis inhibitors Bevacizumab Carcinoma colorectal Irinotecan Observational study Ramucirumab POST-PROGRESSION SURVIVAL DOUBLE-BLIND PHASE-III BEVACIZUMAB FOLFIRI RAMUCIRUMAB OXALIPLATIN IRINOTECAN CARCINOMA RESECTION

发布时间 2022-07-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer

相似文献

同项目论文

相关期刊

检索历史 清除

Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer

相似文献

同项目论文

相关期刊

检索历史清除